Frontiers in Neuroendocrinology, Volume 65, April 2022

In vitro and in vivo studies showed that melatonin therapy is effective against AD. The emerging novel melatonin-based therapies are potential treatment options in AD.

Free Radical Biology and Medicine, Volume 183, April 2022

In this review, we aim to discuss the multimodal action of genistein as an antioxidant, anti-inflammatory, anti-amyloid β, and autophagy promoter, which could be responsible for the genistein beneficial effect on Alzheimer's.
Cross-sectional and longitudinal soluble TREM2 levels in CSF according to estimated years to symptom onset (EYO) in carriers and non-carriers of pathogenic variants.

The Lancet Neurology, Volume 21, April 2022

An article on Alzheimer's disease progression, in the context of SDG 3, focusing specifically on the dynamics of soluble TREM2 and its association with amyloid and tau markers, neuroimaging features, and cognition.

European Journal of Vascular and Endovascular Surgery, Volume 63, April 2022

This article explores whether operations for carotid artery diseases reduce the risk of dementia.

The Lancet Regional Health - Europe, Volume 15, April 2022

An article on dementia risk, in the context of SDGs 3 and 10, focusing specifically on the association between ethnicity, socioeconomic deprivation, and dementia risk.

The Lancet Healthy Longevity, Volume 3, April 2022

An article on interventions for people with mild dementia, in the context of SDG 3, focusing specifically on the benefits and cost-effectiveness of the Journeying through Dementia intervention in England.
Elsevier, The Lancet Planetary Health, Volume 6, March 2022
A Review on climate change and mental health studies, in the context of SDGs 3 and 13, focusing specifically on key advances and gaps in the field.
Reduction in clinical practice is achieved through the provision of good oral health care.
Editorial highlighting publication of the Consensus on Environmentally Sustainable Oral Healthcare: A Joint Stakeholder Statement.